Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study have?
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study has 170 citations in the OpenAlex counts ScholarIQ stores.
When was Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study published?
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study has 2019 year in the ScholarIQ index.
What is the open-access status of Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study?
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study has closed oa status in the ScholarIQ index.
What is the DOI of Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study?
The DOI for Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study is on the source record.
What is the PMID of Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study?
The PMID for Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study is on the source record.
What is the OpenAlex record for Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study?
The OpenAlex for Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study is on the source record.